Central Illustration.
Key Elements of the Cardiovascular Cell Therapy Research Network’s SENECA Trial
Key elements highlighted in the Cardiovascular Cell Therapy Research Network’s SENECA trial include the etiology of anthracycline-induced cardiomyopathy, in survivors of diverse cancers, and the notable findings demonstrating safety and feasibility of transendocardial administration allogeneic mesenchymal stromal cells.